ADHD is typically treated with a stimulant medication or atomoxetine, a non-stimulant.
Each of these medications has been linked to specific risks in patients who have bipolar disorder.
With stimulants, doctors are primarily concerned with causing manic episodes in patients with bipolar disorder.
The FDA has placed a warning label on Adderall, alerting clinicians to the risk of causing manic episodes in bipolar patients.
This risk is concerning enough that the warning recommends screening patients with depressive symptoms to see if they have Bipolar Disorder that they may not be aware of yet.
A manic episode is one of the key defining features of Bipolar Disorder. Itโs characterized by an elevated or irritable mood and goal-directed behavior for at least one week, nearly every day:
One study estimated that an individual with bipolar disorder who takes Ritalin for ADHD has a nearly 7-fold greater risk of mania, if taken alone.
This finding tells us that Ritalin can cause mania in individuals with ADHD.
The same study also found that when Ritalin was given with a mood stabilizer, individuals had a slightly lower risk of mania than before treatment, suggesting that Ritalin can be safely administered as long as it was given with a mood stabilizer.
A separate study below showed that Adderall did not increase mania risk or symptoms in children with bipolar disorder if given along with a mood stabilizer. This finding is consistent with the Ritalin study above.
Like Ritalin, Adderall can be a treatment option for ADHD in Bipolar Disorder.
In fact, some experts recommend using it as a potential treatment for Bipolar Disorder symptoms if other medications don't work, though this view remains controversial:
Strattera is a non-stimulant medication used for ADHD. While it has a different mechanism of action than Ritalin or Adderall, some data suggest that it may worsen Bipolar Disorder symptoms as well.
There have been several cases of hypomania reported as a result of Strattera in patients with bipolar disorder:
While these case reports donโt tell us how frequent or how strong the link between Strattera and hypomania might be, they do alert us to potential risks that should be weighed with the benefits of Strattera in individuals who may have Bipolar Disorder: